Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.

de Pokomandy A, Kaufman E, de Castro C, Mayrand MH, Burchell AN, Klein M, Charest L, Auger M, Rodrigues-Coutlée S, Coutlée F; EVVA Study Group.

J Infect Dis. 2017 Aug 15;216(4):447-456. doi: 10.1093/infdis/jix273.

PMID:
28931234
2.

Argon plasma coagulation treatment of anal high-grade squamous intraepithelial lesions in men who have sex with men living with HIV: results of a 2-year prospective pilot study.

de Pokomandy A, Rouleau D, Lalonde R, Beauvais C, de Castro C, Coutlée F; Human Immunodeficiency and Papilloma Virus Research Group (HIPVIRG) Study Group.

HIV Med. 2017 Aug 23. doi: 10.1111/hiv.12544. [Epub ahead of print]

PMID:
28833949
3.

Sequence-specific backbone resonance assignments and microsecond timescale molecular dynamics simulation of human eosinophil-derived neurotoxin.

Gagné D, Narayanan C, Bafna K, Charest LA, Agarwal PK, Doucet N.

Biomol NMR Assign. 2017 Mar 7. doi: 10.1007/s12104-017-9736-9. [Epub ahead of print]

PMID:
28271277
4.

Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.

Thomas R, Galanakis C, Vézina S, Longpré D, Boissonnault M, Huchet E, Charest L, Murphy D, Trottier B, Machouf N.

PLoS One. 2015 Nov 11;10(11):e0142534. doi: 10.1371/journal.pone.0142534. eCollection 2015.

5.

Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.

Cao W, Mehraj V, Trottier B, Baril JG, Leblanc R, Lebouche B, Cox J, Tremblay C, Lu W, Singer J, Li T, Routy JP; Montreal Primary HIV Infection Study Group, Vézina S, Charest L, Milne M, Huchet E, Lavoie S, Friedman J, Duchastel M, Villielm F, Côté P, Potter M, Lessard B, Charron MA, Dufresne S, Turgeon ME, Rouleau D, Labrecque L, Fortin C, de Pokomandy A, Hal-Gagné V, Munoz M, Deligne B, Martel-Laferrière V, Gilmore N, Fletcher M, Szabo J.

Clin Infect Dis. 2016 Jan 15;62(2):250-257. doi: 10.1093/cid/civ809. Epub 2015 Sep 8.

6.

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

Jenabian MA, El-Far M, Vyboh K, Kema I, Costiniuk CT, Thomas R, Baril JG, LeBlanc R, Kanagaratham C, Radzioch D, Allam O, Ahmad A, Lebouché B, Tremblay C, Ancuta P, Routy JP; Montreal Primary infection and Slow Progressor Study Groups.

J Infect Dis. 2015 Aug 1;212(3):355-66. doi: 10.1093/infdis/jiv037. Epub 2015 Jan 23.

PMID:
25616404
7.

Tolerability is more important than simplicity for treatment durability.

Trottier B, Machouf N, Huchet E, Lavoie S, Vezina S, Boissonnault M, Charest L, Munoz M, Legault D, Longpré D, Thomas R.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19765. doi: 10.7448/IAS.17.4.19765. eCollection 2014.

8.

HIV Nef promotes expression of B-lymphocyte stimulator by blood dendritic cells during HIV infection in humans.

Chagnon-Choquet J, Gauvin J, Roger J, Fontaine J, Poudrier J, Roger M; Montreal Primary HIV Infection and Slow Progressor Study Groups.

J Infect Dis. 2015 Apr 15;211(8):1229-40. doi: 10.1093/infdis/jiu611. Epub 2014 Nov 6.

PMID:
25378636
9.

IL-10 and lymphotoxin-α expression profiles within marginal zone-like B-cell populations are associated with control of HIV-1 disease progression.

Chagnon-Choquet J, Fontaine J, Poudrier J, Roger M; Montreal Primary HIV Infection Study Group; Slow Progressor Study Group.

PLoS One. 2014 Jul 8;9(7):e101949. doi: 10.1371/journal.pone.0101949. eCollection 2014.

10.

Conservation of flexible residue clusters among structural and functional enzyme homologues.

Gagné D, Charest LA, Morin S, Kovrigin EL, Doucet N.

J Biol Chem. 2012 Dec 28;287(53):44289-300. doi: 10.1074/jbc.M112.394866. Epub 2012 Nov 7.

11.

Transmission clustering drives the onward spread of the HIV epidemic among men who have sex with men in Quebec.

Brenner BG, Roger M, Stephens D, Moisi D, Hardy I, Weinberg J, Turgel R, Charest H, Koopman J, Wainberg MA; Montreal PHI Cohort Study Group.

J Infect Dis. 2011 Oct 1;204(7):1115-9. doi: 10.1093/infdis/jir468.

12.

Episomal and integrated human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men.

Alvarez J, de Pokomandy A, Rouleau D, Ghattas G, Vézina S, Coté P, Allaire G, Hadjeres R, Franco EL, Coutlée F; HIPVIRG Study Group.

AIDS. 2010 Sep 24;24(15):2355-63. doi: 10.1097/QAD.0b013e32833db9ea.

PMID:
20706109
13.

Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study.

de Pokomandy A, Rouleau D, Ghattas G, Vézina S, Coté P, Macleod J, Allaire G, Franco EL, Coutlée F; HIPVIRG Study Group.

J Infect Dis. 2009 Apr 1;199(7):965-73. doi: 10.1086/597207.

PMID:
19239366
14.

HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease.

Fontaine J, Coutlée F, Tremblay C, Routy JP, Poudrier J, Roger M; Montreal Primary HIV Infection and Long-Term Nonprogressor Study Groups.

J Infect Dis. 2009 Apr 1;199(7):1007-18. doi: 10.1086/597278.

PMID:
19231994
15.

Transmission networks of drug resistance acquired in primary/early stage HIV infection.

Brenner BG, Roger M, Moisi DD, Oliveira M, Hardy I, Turgel R, Charest H, Routy JP, Wainberg MA; Montreal PHI Cohort and HIV Prevention Study Groups.

AIDS. 2008 Nov 30;22(18):2509-15. doi: 10.1097/QAD.0b013e3283121c90.

16.

Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia.

Gohy L, Gorska I, Rouleau D, Ghattas G, Pokomandy Ad, Vézina S, Coté P, Macleod J, Allaire G, Hadjeres R, Kornegay JR, Franco E; HIPVIRG Study Group, Coutlée F.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):32-9. doi: 10.1097/QAI.0b013e318183a905.

PMID:
18667921
17.

The increased susceptibility of women to multiple sclerosis.

Duquette P, Pleines J, Girard M, Charest L, Senecal-Quevillon M, Masse C.

Can J Neurol Sci. 1992 Nov;19(4):466-71. Review.

PMID:
1423044
18.

Growth hormone rebound after cessation of sms 201-995 treatment in acromegaly.

Charest L, Comtois R, Beauregard H, Serri O.

Can J Neurol Sci. 1989 Nov;16(4):442-5.

PMID:
2804808
19.

Cerebrospinal fluid findings in healthy siblings of multiple sclerosis patients.

Duquette P, Charest L.

Neurology. 1986 May;36(5):727-9.

PMID:
3703275
20.

Interaction between sex and HLA in a population study.

Charest L, Duquette P.

Arch Neurol. 1984 Jul;41(7):703-4. No abstract available.

PMID:
6743052

Supplemental Content

Loading ...
Support Center